$24-Million Public-Private Partnership to Expand Investigation


The Michael J. Fox Foundation (MJFF), the National Institutes of Health (NIH) and five life sciences companies  announced a public-private partnership to advance understanding, measurement and treatment of Parkinson’s disease. The latest focus of the NIH Accelerating Medicines Partnership (AMP) model, this new AMP PD project will apply cutting-edge technologies to tease apart microscopic differences in the cells of people with Parkinson’s disease (PD).

To know more: